In conclusion, we have reported the altered expression of miR-27a in human lung adenocarcinoma cell lines with different sensitivities to cisplatin, and have shown that miR-27a could modulate cisplatin resistance and metastasis in these cells by targeting RKIP. This evidence concerns the gene PEBP1 and lung adenocarcinoma.